Managing PPMS: a doctor's perspective

Roche
Roche
234,332
0
Published 2017-04-24
Dr. Jerome de Seze, Department Head of Neurology and Clinical Investigation Centre at the University of Strasbourg, shares his experience with managing the treatment of primary progressive multiple sclerosis (PPMS), a particularly rare, difficult-to-diagnose and difficult-to-manage form of MS that tends to occur around the age of 40. MS is a disease of the central nervous system that has a course and symptoms that vary from person to person.

To learn more about Roche and MS, visit www.roche.com/ms.

Subscribe to our YouTube channel now: youtube.com/user/roche?sub_confirmation=1

Get in touch with us:

www.roche.com/
www.facebook.com/RocheCareers
www.linkedin.com/company/roche
twitter.com/roche

Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.

Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.

For more information and insights visit: www.roche.com/
All Comments (5)
  • @nottoday9182
    No disrespect to the French, however subtitles would have made him understandable.
  • @sweetov5
    Alot of videos i watch forget to mention cognitive problems that get progressively worst.